Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLQ223 and Zidovudine in Symptomatic HIV-Infected Patients
NCT00001989Phase 2Completed
- Sponsor
- Genelabs Technologies
- Modality
- Recombinant Proteins and Enzymes, Plant Toxin Conjugates, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
Phase 2, randomised trial of trichosanthin in human immunodeficiency virus infection (HIV), sponsored by Genelabs Technologies. Status: completed.
02
Drugs
trichosanthin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001989.